- Home
- HST vs QGEN Comparison
HST vs QGEN Comparison
Compare HST & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HST
- QGEN
- Stock Information
- Founded
- HST 1927
- QGEN 1986
- Country
- HST United States
- QGEN Netherlands
- Employees
- HST N/A
- QGEN N/A
- Industry
- HST Real Estate Investment Trusts
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HST Real Estate
- QGEN Health Care
- Exchange
- HST Nasdaq
- QGEN Nasdaq
- Market Cap
- HST 11.9B
- QGEN 9.9B
- IPO Year
- HST N/A
- QGEN 1996
- Fundamental
- Price
- HST $14.27
- QGEN $39.85
- Analyst Decision
- HST Buy
- QGEN Buy
- Analyst Count
- HST 14
- QGEN 8
- Target Price
- HST $19.54
- QGEN $49.79
- AVG Volume (30 Days)
- HST 9.7M
- QGEN 1.1M
- Earning Date
- HST 04-30-2025
- QGEN 04-28-2025
- Dividend Yield
- HST 6.31%
- QGEN 3.30%
- EPS Growth
- HST N/A
- QGEN N/A
- EPS
- HST 0.99
- QGEN 0.37
- Revenue
- HST $5,691,000,000.00
- QGEN $1,978,214,000.00
- Revenue This Year
- HST $4.76
- QGEN $5.15
- Revenue Next Year
- HST $3.02
- QGEN $6.49
- P/E Ratio
- HST $14.41
- QGEN $107.16
- Revenue Growth
- HST 7.03
- QGEN 0.66
- 52 Week Low
- HST $14.15
- QGEN $37.63
- 52 Week High
- HST $20.85
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- HST 32.60
- QGEN 49.85
- Support Level
- HST $14.25
- QGEN $39.35
- Resistance Level
- HST $15.14
- QGEN $40.11
- Average True Range (ATR)
- HST 0.42
- QGEN 0.54
- MACD
- HST -0.03
- QGEN 0.18
- Stochastic Oscillator
- HST 6.78
- QGEN 80.88
About HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 81 predominantly urban and resort upper-upscale and luxury hotel properties representing over 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).